| Literature DB >> 33432048 |
Takuya Ishikawa1, Hiroki Kawashima2, Eizaburo Ohno3, Tadashi Iida3, Hirotaka Suzuki3, Kota Uetsuki3, Jun Yashika3, Kenta Yamada2, Masakatsu Yoshikawa3, Noriaki Gibo3, Toshinori Aoki3, Kunio Kataoka3, Hiroshi Mori3, Takeshi Yamamura3, Kazuhiro Furukawa3, Masanao Nakamura3, Yoshiki Hirooka4, Mitsuhiro Fujishiro3.
Abstract
Autoimmune pancreatitis (AIP) is recognized as the pancreatic manifestation of a systemic IgG4-related disease that can involve various organs, including the kidney. However, renal lesions tend to be overlooked when AIP is diagnosed, and the clinical characteristics and long-term prognosis of AIP with renal lesions are unclear. We retrospectively reviewed 153 patients with AIP diagnosed at our hospital with a median follow-up period of 41 months (interquartile range, 10-86) and classified them into two groups: the KD group (n = 17), with characteristic renal imaging features, and the non-KD group (n = 136). Serum IgG4 levels were significantly higher in the KD group (663 vs. 304.5 mg/dl, P = 0.014). No differences were observed between the two groups in terms of steroid treatment [14/17 (82.4%) vs. 112/136 (82.4%), P = 1] or in the number of patients who exhibited exacerbation of renal function during treatment [1/17 (5.9%) vs. 8/136 (5.9%), P = 1]. However, the cumulative relapse rate was significantly higher in the KD group [61% vs. 21.9% (3 years), P < 0.001]. Patients in the KD group had different clinical features with high relapse rates compared with those in the non-KD group, and thus, it is important to confirm the presence of renal lesions in AIP patients.Entities:
Year: 2021 PMID: 33432048 PMCID: PMC7801504 DOI: 10.1038/s41598-020-79899-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379